CEO Q&A with Geremy Thomas at Sativa Investments PLC (NEX:SATI)

Sativa Investments PLC (NEX:SATI) Chief Executive Officer Geremy Thomas caught up with DirectorsTalk for an exclusive interview to discuss the background to the company, seeking approval for a change in investment policy, the UK’s position in the medicinal cannabis global market and similar companies in the UK.

 

Q1: Sativa is a relatively new company in the eyes of investors. You floated of the NEX exchange in March of this year, can you explain for us what exactly Sativa Investment does?

A1: We are an investment vehicle allowing UK investors to invest in medicinal cannabis. Medicinal cannabis is attracting a lot of interest in markets around the world including Canada, 28 states in America, Israel, the Netherlands and, closer to us here, in Germany.

 

Q2: We’ve just seen that you’re seeking shareholder approval for a change in investment policy, why is that?

A2: We started off focussing on the Canadian market, Canada was first licenced for medicinal cannabis in 2001 and has the most robust and proven regulatory regime. Since we been on the market, there’s been heightened awareness certainly here in the UK and the opening of the German market, it’s been deemed appropriate to widen that brief so that we can invest in any regulated market around the world and, indeed, the UK.

 

Q3: Where does the UK fit in the global market for medicinal cannabis?

A3: Currently, there is no legal framework for patients to benefit from medicinal cannabis here in the UK. Public opinion has shifted considerably in the last 12 months and there are moves within government to hasten the pace of change here in the UK.

If we look at the size of the Canadian market with just less than 38 million people and a $5 billion medicinal cannabis business, one could project the size of the UK market with over 70 million people here to be one of the biggest in the world when it happens.

 

Q4: Are there any other similar businesses to Sativa Investments in the UK?

A4: On the AIM market, 4 years, GW Pharma raised a considerable amount of interest, they are a producer of medicinal cannabis here in England, but they produce it for export purposes. They moved to the NASDAQ market because, at the time, the UK market was not receptive, didn’t understand what they were doing, but they’ve gone on now to be a CAN$4 billion Canadian valued company. So, yes, there is precedent and GW Pharma has gone on to be an extremely valuable business.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Sativa Investments plc

    More articles like this

    DirectorsTalk

    CBD as a novel food: the UK’s stance post-Brexit

    The UK FSA’s announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the European Commission during the summer of 2020, who have currently ‘paused’ novel food

    DirectorsTalk

    What cannabinoids are found in CBD oils?

    CBD oils can be purely made from seeds or they can be a combination of cannabinoids, flavonoids, and terpenes. Every CBD oil is a little bit different, and you will want to make sure you read

    DirectorsTalk

    How the UK CBD industry is thriving in uncertain times

    This year covid-19 has hit hard with far-reaching economic implications for countries around the world. The United Kingdom is no exception as the economy has taken the brunt of the pandemic’s negative effects. However certain markets

    DirectorsTalk

    UK CBD market on a high

    Just when you thought the ‘hype’ around CBD adoption was a passing fad, UK’s nascent CBD market happens to be among the few industries maintaining an upward growth amidst the recent COVID-19 pandemic devastation in the

    DirectorsTalk

    How to integrate CBD oil into your diet

    The internet is awash with information and testimonies on the benefits of CBD oil and the potential that it has in alleviating a number of ailments. Whether or not some of these claims are true is

    DirectorsTalk

    Why should you choose CBD oil?

    Cannabidiol (CBD) is a non-psychoactive yet active chemical component among cannabinoids, a group of compounds found in marijuana plants otherwise known as Cannabis sativa. Conversely, Tetrahydrocannabinol (THC) is the principal psychoactive component that causes an intoxicating

    DirectorsTalk

    A guide to CBD

    What is CBD? CBD – It’s a relatively new product, but how can it benefit you? Most people haven’t even heard of it and yet it’s starting to appear in conversations around sports, food and beauty

    Sativa Group

    Is CBD oil legal in the UK?

    The legal status of CBD in the UK is reflected in many countries worldwide, with the main difference being the levels of THC allowed in the finished product. CBD has seen such a rapid rise to

    Sativa Group

    Sativa Group joins the ACI toxicology study

    As part of the Sativa Group PLC (AQUIS:SATI) ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the

    Sativa Group

    A comprehensive guide to CBD in the UK

    CBD is being added to products across the retail spectrum from food to make-up. According to claims by the Centre for Medical Cannabis, six million people in the UK have tried CBD, and this year the

    Sativa Group

    A new cannabis wellness era: A history of CBD

    Cannabis Sativa L. has been utilised for a large variety of ailments, industrial applications, and ceremonial uses for millennia. Evidence gathered from significant ancient sites has revealed that the plant was important, and even sacred, in

    Sativa Group

    How CBD can help level up your workout

    With gyms closed and group classes relegated to the online world, at-home workouts are the new normal. Feeling a bit lackluster after months of squats in your living room? Want a new solution so you can

    Sativa Group

    What is CBD? How does it work?

    What is CBD? It’s in everything from beauty products to lattes, but those three letters are thrown around so much that you’d be forgiven for not knowing what CBD is, exactly. More importantly, you might be wondering, is CBD safe?

    Sativa Group

    Sativa Group CSE conditionally approves Sativa Wellness Group

    Sativa Group plc (AQUIS:SATI) has announced that the Canadian Securities Exchange conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously